ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NEW OPTURA®PALM® Handheld Contactless Biomass Sensor from Aber Offers Accurate Cell Density Measurement in Seconds Without Sampling
August 09, 2024Aber Instruments (Aber) is delighted to introduce its new OPTURA® PALM® handheld biomass sensor. -
Freudenberg Expands Biopharma Product Portfolio with Single-use Assemblies
August 01, 2024Freudenberg Medical has expanded its biopharma product portfolio to custom single-use assemblies. -
iotaSciences Raises Equity Financing Round to Drive Further Business Expansion for Its Automated Single-Cell Biology Handling Technologies
August 01, 2024New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform. -
British Journal of Cancer: Zurletrectinib Is a Next-Generation TRK Inhibitor With Strong Intracranial Activity Against NTRK Fusion-Positive Tumors With On-Target Resistance to First-generation Agents
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumors with on-target resistance to first-generation agents. -
Plexium Selects Xavo as Their Sample Management Lab Operations Platform
July 25, 2024Xavo proudly announces Plexium as its latest esteemed client. The collaboration between the two companies marks a significant milestone in Xavo’s journey. -
New Facility Assures Continuity of Supply of Anti-Obesity Treatment CONTRAVE®/MYSIMBA® Amidst GLP-1 Supply Issues
July 24, 2024Currax Pharmaceuticals LLC announced the approval of additional manufacturing site for CONTRAVE®/MYSIMBA® in the European Union and European Union Economic Areas. -
InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 Inhibitor ICP-332 in the U.S.
Beijing, July 24, 2024 – InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases -
Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing
July 24, 2024Touchlight announced a license agreement with GSK, a global leader in biopharmaceutical innovation. -
Medway NHS Foundation Trust to Transform Local Gestational Diabetes Screening by Offering World-First Home Oral Glucose Tolerance Testing (OGTT) Technology to All At-Risk Women
July 22, 2024Digostics and Medway NHS Foundation Trust announced a partnership that will see the Trust become the latest maternity services provider to extend new remote OGTT to all expectant mothers who are at risk of developing gestational diabetes mellitus . -
Dermaliq Therapeutics Announces Positive Topline Results from Phase 1b/2a Trial Evaluating the Safety and Efficacy of DLQ01 for the Treatment of Androgenetic Alopecia (AGA) in Men
July 17, 2024DLQ01 is potentially the first new topical treatment option for both men and women suffering from AGA in a very long time.
Pharma Sources Insight January 2025
